No. 1 Biotech Stock Neurocrine Launches Higher On Depression Treatment Win
investors.com/news/technology/biotech-stock-neurocrine-stock-depression-treatment-win
Top-notch biotech stock Neurocrine launched higher Tuesday after the company's depression treatment succeeded in a midstage study.
The post No. 1 Biotech Stock Neurocrine Launches Higher On Depression Treatment Win appeared first on Investor's Business Daily.
This story appeared on investors.com, 2024-04-23.